Suppliers / Shandong Chenzhong Biopharmaceutical

Shandong Chenzhong Biopharmaceutical

China Updated 9 July 2026

Shandong Chenzhong Biopharmaceutical is an API manufacturer based in China. It holds 3 active US drug master files across a filed portfolio of 3 molecules.

3
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Enoxaparin US FDA 1
Heparin Sodium US FDA 1
Nadroparin US FDA 1

Also appears on these molecule pages

Enoxaparin API Heparin API

Questions about Shandong Chenzhong Biopharmaceutical

Does Shandong Chenzhong Biopharmaceutical hold a US DMF or a CEP?
Shandong Chenzhong Biopharmaceutical holds 3 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Shandong Chenzhong Biopharmaceutical make?
3 molecules are on record against Shandong Chenzhong Biopharmaceutical, including Enoxaparin, Heparin Sodium and Nadroparin. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Shandong Chenzhong Biopharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Apitoria Pharma shares 1 molecule Gland Pharma shares 1 molecule Dongying Tiandong Pharmaceutical shares 1 molecule Hebei Changshan Biochemical Pharmaceutical shares 1 molecule Hubei Enoray Biopharmaceutical shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability